Emalex received FDA authorization for an Expanded Access Program for its investigational Tourette syndrome drug. New Drug ...

Emalex Biosciences’ Expanded Access Programme for investigational Tourette syndrome drug, ecopipam receives US FDA authorization: Chicago Friday, October 10, 2025, 18:00 Hrs [IS ...

Three research hospitals in the Republic of Korea are reporting that restless leg syndrome was associated with an increased ...

Chew Worm Lab imageIn a discovery that could reshape how we think about memory, researchers at Flinders University have found ...

A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...

Nausea and Vomiting Are the Most Frequent Reasons for Discontinuing GLP-1 Therapies, Significantly Impacting Adherence, Titration and Preventing ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

There is a saying never trust a man that doesn’t drink but what happens when you don’t trust yourself anymore?

Three South Korean research hospitals have learned that 1.6% of patients with restless legs syndrome develop Parkinson's ...

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

Nicotine withdrawal symptoms often include cravings, irritability, and weight gain. Certain medications and lifestyle changes ...